REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $235,032 | +3.0% | 20,491 | +127.3% | 0.00% | 0.0% |
Q2 2023 | $228,119 | +0.5% | 9,013 | +27.9% | 0.00% | -50.0% |
Q1 2023 | $227,048 | -2.2% | 7,049 | -44.0% | 0.00% | 0.0% |
Q4 2022 | $232,227 | +31.2% | 12,580 | -1.7% | 0.00% | 0.0% |
Q2 2022 | $177,000 | -26.2% | 12,793 | -13.1% | 0.00% | +100.0% |
Q4 2021 | $240,000 | +10.6% | 14,724 | +88.7% | 0.00% | 0.0% |
Q3 2021 | $217,000 | -3.1% | 7,801 | -1.4% | 0.00% | -50.0% |
Q4 2020 | $224,000 | – | 7,912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |